LDL = 5: Virtues and Dangers of Multidrug Therapy of Low-Density Lipoprotein Cholesterol

William Phillips, Saul Schaefer

Research output: Contribution to journalArticle

Abstract

Multiple-drug therapy of dyslipidemia is frequently used to achieve treatment goals in high-risk patients with coronary artery disease. The authors report a case of a patient treated with a statin, fibrate, ezetimibe, and niacin in whom a calculated low-density lipoprotein cholesterol level of 5 mg/dL was achieved.Prev Cardiol. 2010;13:69-71.©2009 Wiley Periodicals, Inc.

Original languageEnglish (US)
Pages (from-to)69-71
Number of pages3
JournalPreventive Cardiology
Volume13
Issue number2
DOIs
StatePublished - Mar 2010

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Public Health, Environmental and Occupational Health

Cite this